References
- Herzog CE. Benign vascular tumors. In : Behrman RE, Kliegman RM, Jenson HB editors. Nelson textbook of pediatrics. 17th ed. Philadelphia : WB Saunders Co, 2004:1726
- Ho V, Krol A, Bhargava R, Osiovich H. Diffuse neonatal haemangiomatosis. J Paediatr Child Health 2000;36:286-9 https://doi.org/10.1046/j.1440-1754.2000.00491.x
- Stenninger E, Schollin J. Diffuse neonatal hemangiomatosis in a newborn child. Acta Paediatr 1993;82:102-4
- Stratte EG, Tope WD, Johnson CL, Swanson NA. Multimodel management of diffuse neonatal hemangiomatosis. J Am Acad Dermatol 1996;34:337-42 https://doi.org/10.1016/S0190-9622(07)80004-1
- Lopriore E, Markhorst DG. Diffuse neonatal hemangiomatosis : new views on diagnostic criteria and prognosis. Acta Paediatr 1999;88:93-7
- Castello MA, Ragni G, Antimi A, Todini A, Patti G, Lubrano R, et al. Successful management with interferon alpha-2a after prednisone therapy failure in an infant with a giant cavernous hemangioma. Med Pediatr Oncol 1997; 28:213-5 https://doi.org/10.1002/(SICI)1096-911X(199703)28:3<213::AID-MPO12>3.0.CO;2-F
- Metry DW, Hebert AA. Benign cutaneous vascular tumors of infancy : when to worry, what to do. Arch Dermatol 2000;136:905-14 https://doi.org/10.1001/archderm.136.7.905
- Perez J, Pardo J, Gomez C. Vincristine-an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncologica 2002;41:197-9 https://doi.org/10.1080/028418602753669607
- Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, Donald DM, Folkman J, et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998;132:527-30 https://doi.org/10.1016/S0022-3476(98)70034-4
- Michaud AP, Bauman NM, Burke DK, Manaligod JM, Smith RJH. Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope 2004;114:1231-6 https://doi.org/10.1097/00005537-200407000-00017
- Enjolras O, Breviere GM, Roger G, Tovi M, Pellegrino B, Varotti E, et al. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr 2004;11: 99-107 https://doi.org/10.1016/j.arcped.2003.10.014
- Ramdohr M. Ein fall von angebornem multiplen angiosarcom. Virchows Arch Pathol Anat Histol 1878;73:459-60 https://doi.org/10.1007/BF01997676
- Cho HJ, Kim DK, Park KD, Yang CH, Lee JY, Kim KY. A case of diffuse neonatal hemangiomatosis improved with prednisolone and interferon alfa-2a. Korean J Dermatol 1996;34:1039-43
- Seo YW, Lee SY, Lee JS, Whang KU, Lee HK. Diffuse neonatal hemangiomatosis successfully treated with high dose corticosteroid. Ann Dermatol 1998;10:112-5
- Park JH, Lee SJ, Koo SW, Lee JH, Kim YK, Choi GS. A case of diffuse neonatal hemangiomatosis. Korean J Dermatol 2001;39:617-20
- Kim HJ, Kim NI. Diffuse neonatal hemangiomatosis. Ann Dermatol 2003;15:17-20
- Golitz LE, Rudikoff J, O'Meara OP. Diffuse neonatal hemangiomatosis. Pediatr Dermatol 1986;3:145-52. https://doi.org/10.1111/j.1525-1470.1986.tb00506.x
- MacArther CJ, Sinders CW, Katz J. The use of interferon alfa-2a for life threatening hemangiomas. Arch Otolaryngol Head Neck Surg 1995;121:117-20
- Fawcett SL, Grant I, Hall PN, Kelsall AW, Nicholson JC. Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg 2004;57:168-71 https://doi.org/10.1016/j.bjps.2003.11.003
- Rowinsky EK, Donehower RC. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol Ther 1991;52:35-84 https://doi.org/10.1016/0163-7258(91)90086-2